Literature DB >> 27671681

Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.

Preshanta Naicker1,2, Shailendra Anoopkumar-Dukie1,2, Gary D Grant1,2, Justin J Kavanagh3,4.   

Abstract

RATIONALE: Acetylcholine is an important neuromodulator in the central nervous system, where it plays a significant role in central functions such as the regulation of movement.
OBJECTIVE: This study investigated the pharmacological effects of over-the-counter anticholinergic medications on saccadic and smooth pursuit eye movements, in order to establish the significance of central cholinergic pathways in the control of these centrally regulated oculomotor processes.
METHODS: Sixteen subjects (mean age 23 ± 3 years, 9 females) performed pro-saccadic, anti-saccadic and smooth pursuit eye movement tests, while an eye tracker collected eye movement data. Oculomotor assessments were performed pre-ingestion, 0.5 and 2 h post-ingestion of drugs with varying degrees of central anticholinergic properties. The drugs tested were promethazine, hyoscine hydrobromide, hyoscine butylbromide and placebo.
RESULTS: The drug intervention with stronger central anticholinergic properties, promethazine, decreased amplitude and increased velocity in the pro-saccadic task and increased duration in the anti-saccadic task. Promethazine, once again, was the only drug to decrease eye velocity in the smooth pursuit test.
CONCLUSION: The prominent effects of the stronger central anticholinergic promethazine, on saccadic and smooth pursuit eye movements, potentially conveys the significance of central cholinergic pathways in the control of these centrally regulated oculomotor processes.

Entities:  

Keywords:  Anticholinergic; Neurotransmitter; Oculomotor; Saccadic eye movement; Smooth pursuit

Mesh:

Substances:

Year:  2016        PMID: 27671681     DOI: 10.1007/s00213-016-4436-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

Review 1.  Role of the basal ganglia in the control of purposive saccadic eye movements.

Authors:  O Hikosaka; Y Takikawa; R Kawagoe
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

Review 2.  Sensory-motor gating and cognitive control by the brainstem cholinergic system.

Authors:  Yasushi Kobayashi; Tadashi Isa
Journal:  Neural Netw       Date:  2002 Jun-Jul

Review 3.  Action of anticholinergic drugs on striatal dopamine.

Authors:  S H Snyder
Journal:  Pharmacol Ther B       Date:  1976

Review 4.  Acetylcholine-dopamine balance hypothesis in the striatum: an update.

Authors:  Toshihiko Aosaki; Masami Miura; Takeo Suzuki; Kinya Nishimura; Masao Masuda
Journal:  Geriatr Gerontol Int       Date:  2010-07       Impact factor: 2.730

5.  Drowsiness and motor responses to consecutive daily doses of promethazine and loratadine.

Authors:  Lyndsee Baumann-Birkbeck; Gary D Grant; Shailendra Anoopkumar-Dukie; Justin J Kavanagh
Journal:  Clin Neurophysiol       Date:  2014-04-12       Impact factor: 3.708

Review 6.  The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.

Authors:  Inge Klinkenberg; Arjan Blokland
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

7.  Utility of saccadic eye movement analysis as an objective biomarker to detect the sedative interaction between opioids and sleep deprivation in opioid-naive and opioid-tolerant populations.

Authors:  Peter M Grace; Tyman Stanford; Melanie Gentgall; Paul E Rolan
Journal:  J Psychopharmacol       Date:  2010-02-08       Impact factor: 4.153

8.  Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia.

Authors:  S B Hutton; T J Crawford; H Gibbins; I Cuthbert; T R Barnes; C Kennard; E M Joyce
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

9.  Smooth pursuit and saccadic abnormalities in first-episode schizophrenia.

Authors:  S B Hutton; T J Crawford; B K Puri; L J Duncan; M Chapman; C Kennard; T R Barnes; E M Joyce
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

10.  Effect of cholinergic and anticholinergic agents on tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.